A Phase 2, Multicenter, Randomized, Double-Blind, Vehicle Controlled, Clinical Study to Compare the Safety and Efficacy of IDP-126 Gel to Epiduo Forte Gel (0.3% Adapalene/2.5% BPO), in the Treatment of Acne Vulgaris
Latest Information Update: 24 Oct 2022
At a glance
- Drugs Adapalene/benzoyl peroxide/clindamycin phosphate (Primary) ; Adapalene/benzoyl peroxide
- Indications Acne vulgaris
- Focus Therapeutic Use
- Sponsors Bausch Health Companies
- 14 Oct 2022 Status changed from active, no longer recruiting to completed.
- 12 Oct 2022 This trial was completed in Belgium, according to European Clinical Trials Database record.
- 13 Jul 2022 Status changed from recruiting to active, no longer recruiting.